Search by Drug Name or NDC

NDC 00143-9292-01 Thiotepa 100 mg/1 Details

Thiotepa 100 mg/1

Thiotepa is a INTRACAVITARY; INTRAVENOUS; INTRAVESICAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is THIOTEPA.

MedlinePlus Drug Summary

Thiotepa is used to treat certain types of ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed), breast, and bladder cancer. It is also used to treat malignant effusions (a condition when fluid collects in the lungs or around the heart) that are caused by cancerous tumors. Thiotepa is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

Related Packages: 00143-9292-01
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Thiotepa Injection

Product Information

NDC	00143-9292
Product ID	0143-9292_f18a13d2-83c0-42a1-8980-60b228c23ab9
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Thiotepa
Proprietary Name Suffix	n/a
Non-Proprietary Name	Thiotepa
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	THIOTEPA
Labeler Name	Hikma Pharmaceuticals USA Inc.
Pharmaceutical Class	Alkylating Activity [MoA], Alkylating Drug [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA211755
Listing Certified Through	2024-12-31

Package

NDC 00143-9292-01 (00143929201)

Pricing Information	N/A
NDC Package Code	0143-9292-01
Billing NDC	00143929201
Package	1 VIAL in 1 BOX, UNIT-DOSE (0143-9292-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Marketing Start Date	2023-09-29
NDC Exclude Flag	N